The firm’s stock price fluctuated 2.34% within the last five trades and -2.65% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the ...
JP Morgan lowered the price target for the Banco Macro S.A. ADR (NYSE:BMA) stock from “a Neutral” to “an Underweight”. The rating was released on January 31, 2022, accordi ...
William Blair raised the price target for the Sight Sciences Inc (NASDAQ:SGHT) stock from “an Outperform” to “a Mkt perform”. The rating was released on September 12, 2023, according to finviz. We ...
Jefferies raised the price target for the Compugen Ltd (NASDAQ:CGEN) stock from “a Buy” to “a Hold”. The rating was released on August 05, 2022, according to finviz. The research report from Stifel ...
Maxim Group raised the price target for the Arbe Robotics Ltd (NASDAQ:ARBE) stock to “a Buy”. The rating was released on February 04, 2022, according to finviz. We previously noted in another research ...
Alliance Global Partners raised the price target for the KNOT Offshore Partners LP (NYSE:KNOP) stock from “a Neutral” to “a Buy”. The rating was released on May 30, 2023, according to finviz. The ...
ROTH Capital raised the price target for the U.S. Gold Corp (NASDAQ:USAU) stock to “a Buy”. The rating was released on November 28, 2017, according to finviz.
Canaccord Genuity lowered the price target for the Oramed Pharmaceuticals, Inc (NASDAQ:ORMP) stock from “a Buy” to “a Hold”. The rating was released on January 12, 2023, according to finviz. The ...
Riley Securities raised the price target for the Lindblad Expeditions Holdings Inc (NASDAQ:LIND) stock to “a Buy”. The rating was released on November 10, 2023, according to finviz. The research ...
ROTH Capital lowered the price target for the PEDEVCO Corp (AMEX:PED) stock to “a Buy”. The rating was released on April 06, 2015, according to finviz.
The stock is trading -65.14 percent below its 52-week high and 7.68 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a ...
TD Cowen raised the price target for the NewAmsterdam Pharma Company NV (NASDAQ:NAMS) stock to “a Buy”. The rating was released on May 15, 2024, according to finviz. The research report from ...